ESLAW Quarterly Debt To Equity
N/A
30 September 2024
Summary:
ESLAW quarterly debt to equity ratio is not available.ESLAW Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLAW Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ESLAW Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Estrella Immunopharma Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | 0.03(-400.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | -0.01 |
FAQ
- What is the all time high quarterly debt to equity for Estrella Immunopharma?
What is the all time high quarterly debt to equity for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly debt to equity ratio is 0.03